| Literature DB >> 28196145 |
Min Kyu Kim, Won-Tae Kim, Hyun Min Lee, Hong Seo Choi, Yu Ra Jo, Yangsoon Lee, Jaemin Jeong, Dongho Choi, Hee Jin Chang, Dae Shick Kim, Young-Joo Jang, Chun Jeih Ryu.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0169091.].Entities:
Year: 2017 PMID: 28196145 PMCID: PMC5308780 DOI: 10.1371/journal.pone.0172487
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 5CA63 recognizes the residues 226–246 of the p37 protein.
(A) Schematic diagram of recombinant p37 fragments (residues 216–246, 226–246, and 216–240). (B) Individual fusion proteins were expressed in E. coli as fusion proteins with GST tag at the N-terminus and stained with Coomassie Brilliant Blue R250 after SDS-PAGE. (C-D) Western blot analyses of GST-p37 fusion proteins with α-GST (C) and CA63 antibodies (D). Mp37 represents the mycoplasmal p37 protein from the extract of mycoplasma-infected cancer cells. The asterisks indicate partial degradation of GST-p37 fusion proteins.
Fig 6CA279 recognizes the residues 226–246 of the p37 protein.
(A) Schematic diagram of recombinant p37 fragments (residues 216–246, 226–246, and 216–240). (B) Individual fusion proteins were expressed in E. coli as fusion proteins with GST tag at the N-terminus and stained with Coomassie Brilliant Blue R250 after SDS-PAGE. (C-D) Western blot analyses of GST-p37 fusion proteins with α-GST (C) and CA279 antibodies (D). Mp37 represents the mycoplasmal p37 protein from the extract of mycoplasma-infected cancer cells. The asterisks indicate partial degradation of GST-p37 fusion proteins.